ArticleACS central science2026
Cholesterol Crystallization Tests the Limits of Microscopic Reversibility for Molecular Pathways of Growth and Dissolution.
Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A subject often debated in the field of crystallization is whether opposing processes of growth and dissolution abide by microscopic reversibility under conditions far from equilibrium. This is particularly relevant for nonclassical growth pathways such as crystallization by particle attachment (CPA), which is an irreversible process owing to the unique sequence of steps involving precursor attachment to crystal surfaces followed by their disorder-to-order transitions as they integrate into the underlying crystal. The reverse process of crystal dissolution is frequently associated with the retraction of unfinished layers, which is the opposite of classical growth and distinctly different than CPA. Here, we selected cholesterol as a model system based on its prevalence in physiological environments that can switch between conditions of supersaturation (crystal growth) and undersaturation (crystal dissolution). We leverage our recent observations that cholesterol nucleation and growth occur by nonclassical and classical pathways, respectively. Our findings reveal the limits of microscopic reversibility when working in moderately undersaturated solutions where dissolution occurs by a unique nonclassical pathway involving the formation of cholesterol-rich clusters on crystal surfaces. Attempts to regenerate crystal surface growth after clusters are formed reveal they have an irreversible effect on crystallization in ways that potentially inhibit pathological cholesterol precipitation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.